Struggling to control high blood sugar?
Join a
Type 2 Diabetes Research
in San Antonio
Receive up to $3450 For Your Time & Travel
Managing type 2 diabetes can feel overwhelming. If your A1C has been difficult to control even with metformin, you are not alone, and research options may help improve understanding for future participants.
Quality Research is enrolling adults with type 2 diabetes for a clinical research study in San Antonio. The study, sponsored by Novo Nordisk, is evaluating how different doses of an investigational medication called UBT251 may affect blood sugar.
No medical insurance is necessary. No proof of residency is required.
Are you struggling to control high blood sugar?
5 Easy Steps to Get Started With Your Type 2 Diabetes Research
Simply fill out the form below and Submit it.
A study coordinator will contact you for an initial screening to determine if you qualify.
The study coordinator will schedule your consultation and health exam.
Convenient study appointments will be set, and you may receive advanced study-related medication.
You get compensated for your time and travel.
What is the Type 2 Diabetes study?
Purpose: To evaluate the effectiveness of different doses of UBT251, an investigational drug, in lowering blood sugar levels. The study also compares UBT251 with investigational semaglutide and a placebo.
Length:
- Screening: up to 3 weeks to confirm eligibility
- Study treatment: approximately 40 weeks
- Follow-up: approximately 6 weeks
Why consider joining?
By joining, you help researchers learn whether an investigational medication could become an option for adults with type 2 diabetes. Your participation contributes to medical knowledge and may benefit future participants. Participation is voluntary; your decision at every step.
Qualified participants may receive up to $3,450 for time & travel. You may also receive study-related medical exams and regular health checks at no cost if you qualify and complete study visits.
Who can join?
You may qualify if you:
- Are between 18 and 75 years old
- Have type 2 diabetes
- Have been on a stable daily dose of metformin for at least 90 days
- May also be on a stable SGLT2 inhibitor for at least 90 days
- Have an A1C between 7.0 and 10.5 percent
- Have a body mass index between 25 and 50
- Can attend study visits and follow study instructions
- Are willing to collaborate with the study team on weight management goals during the study
What will happen if you join?
- Informed consent: We will explain the study, you will have the opportunity to ask questions, and you will decide whether to join.
- Screening: Health evaluations to confirm eligibility. This may include blood tests, vital signs, and a review of your medical history and current medications.
- Study visits: If you qualify, you will visit our clinic regularly during the treatment period. At these visits, we will check your blood sugar and overall health, review any changes, and provide study medication as directed by the study physician.
- Follow-up: After the treatment period, you will return for follow-up assessments for approximately 6 weeks.
Participation is your choice. You may withdraw from the study at any time.
What is the study medication?
UBT251 is an investigational medication being studied to assess how different doses may affect blood sugar in adults with type 2 diabetes. It is not approved for use outside of research.
Will you receive the study medication? This is a randomized study. You may receive UBT251, investigational semaglutide, or a placebo. A placebo resembles the study medication but lacks active ingredients. To maintain study integrity, you and the study team may not know which treatment you are receiving during the study. In an emergency situation, the study physician can access this information.
What is an “investigational medication”? An investigational medication is a study drug that is still being tested and has not been approved by the FDA for general use. It can only be administered within a clinical research study.
About Type 2 Diabetes
Type 2 diabetes is a chronic condition where your body does not utilize insulin effectively, leading to elevated blood sugar levels. Over time, high blood sugar can impact the heart, eyes, kidneys, nerves, and other organs. Healthy eating, physical activity, and prescribed medications can help manage blood sugar.
Common indications of high blood sugar can include:
- Experiencing excessive thirst or hunger
- Needing to urinate more frequently
- Feeling excessively tired
- Blurred vision
- Slow-healing cuts
Where can I learn more?
Speak with your doctor, or consult with our team. We can explain the study in clear terms and address your questions. You can also refer to trusted resources from diabetes organizations such as the American Diabetes Association.
What are clinical research studies (trials)?
Clinical trials assist researchers in determining if a study medication is safe and how it functions. All trials adhere to strict regulations to safeguard participants:
- Phase 1: Initial human testing to assess safety.
- Phase 2: Testing in individuals with the condition to gather more information on safety and efficacy.
- Phase 3: Larger-scale testing to confirm effectiveness and collect additional safety data.
- Phase 4: Studies conducted after approval to continue gathering information.
Do I Qualify?
Worthwhile for You.. and the World
Quality Research is currently conducting gout clinical trials in San Antonio with promising new investigational medications aimed at providing effective treatments for gout. Once you are diagnosed, we can immediately enroll you in one of our trials, where you may receive up to $1,250 for your time and travel. This opportunity allows you to improve your health while also contributing to important research that could benefit millions of people living with gout. Your participation helps pave the way for more effective therapies and better quality of life for those suffering from this condition.
Call (470) 227-8130
or fill out the form today!
Frequently Asked Questions
This study looks at how well different doses of an investigational medicine called UBT251 may lower blood sugar in adults with type 2 diabetes. The study also includes a comparison with semaglutide and a placebo.
Novo Nordisk sponsors this research. Quality Research conducts the study in San Antonio.
Up to 49 weeks total. This includes up to 3 weeks for screening, about 40 weeks of study treatment, and about 6 weeks of follow-up.
Qualified participants may receive up to $3,450 for Your Time and Travel for time and travel. The exact amount depends on the number of completed study visits and procedures.
No medical insurance necessary. There is no cost for study-related visits, tests, or the study medicine.
No proof of residency required. If you otherwise qualify, you may join.
You should be on a stable dose of metformin, with or without a stable SGLT2 inhibitor, before screening. The study doctor will tell you what to keep taking during the study.
You should be 18 to 75 years old, have an A1C between 7.0 and 10.5 percent, have a BMI between 25 and 50, be on stable metformin with or without an SGLT2 inhibitor for at least 90 days, and be able to attend visits. Other criteria will apply.
A placebo looks like the study medicine but has no active drug. It helps researchers compare results fairly.
To keep the study fair, you and the study team may not know which study group you are in. In an emergency, the study doctor can find out.
UBT251 is investigational. It is not approved by the FDA for general use. It can only be given in a clinical study.
About 20 out of 30 people receive UBT251, about 5 out of 30 receive semaglutide, and about 1 in 6 receive a placebo.
You will have screening visits, regular visits during the 40-week treatment period, and follow-up visits. The team will share your schedule during screening.
Call us as soon as you can at 210-864-8844. We will help you get back on track.
Yes. Joining is your choice. You can stop at any time, for any reason.
Your safety is our top priority. The study follows strict rules and is overseen by trained medical staff. We will check your health at every visit.
Yes. We follow HIPAA and protect your privacy. Your information is handled confidentially.
You will have a final follow-up visit. The study team will discuss next steps and share information with your regular doctor if you wish.
This study may not be right if you are pregnant or planning to become pregnant. The team will review all eligibility details with you.
Quality Research, 303 W. Sunset Rd., Suite 102, San Antonio, TX 78209. We are in the Alamo Heights area with easy parking and public transit.